D. Mcavoy
Memorial Sloan Kettering Cancer Center(US)Clinical Trial Investigators(US)
Publications by Year
Research Areas
CAR-T cell therapy research, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, Anesthesia and Sedative Agents, Intensive Care Unit Cognitive Disorders
Most-Cited Works
- → Cost-Effectiveness of α2 Agonists for Intravenous Sedation in Patients With Critical Illness(2025)1 cited
- → Immunotherapy: A COMPREHENSIVE AND COLLABORATIVE WORKFLOW TO ESTABLISH CUSTOMIZED ENDPOINTS AND BIOMARKERS FOR IMMUNOTHERAPY TRIALS(2023)
- → TEMPORAL RELATIONSHIPS BETWEEN DENDRITIC CELLS, CYTOKINES, AND TREGS IN PRE-GVHD PEDIATRIC PATIENTS(2025)
- → Immunotherapy: DISCOVERY PROTEOMICS FOR ANALYTES TO PREDICT CYTOKINE RELEASE SYNDROME ON DAY OF INFUSION OF CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS(2022)
- → T-CELL PHENOTYPES OF CD28 VS 4-1BB CD19 SPECIFIC CAR T-CELLS FOR PATIENTS WITH B-ALL(2025)
- → Streamlined Production of Tumor-Associated Antigen-Specific T Cells (TAAT) from Antigen-Naïve Donors in a GREX Device Using Autologous Monocyte-Derived Dendritic Cells (MoDC) Manufactured in the Same Device as Antigen Presenting Cells (APC)(2025)
- → NAVIGATING LYMPHOCYTE RECONSTITUTION: INSIGHTS INTO AGVHD PHASES(2024)
- → Impact of Age and acute GVHD on Thymic Reconstitution Post-HCT: Insights from Multicenter Immune Monitoring of Pediatric and Young Adult Patients(2025)
- → Rapid Manufacturing of Monocyte-Derived Dendritic Cells (MoDC) in a GREX Device with a Seamless Transition to the Production of Tumor-Associated Antigen-Specific T Cells (TAAT) in the Same Device(2025)
- → RABBIT ANTITHYMOCYTE GLOBULIN EXPOSURE AFFECTS OUTCOMES: ANCILLARY ANALYSIS FROM BMT CTN 1202(2024)